TGFB1 and aortic valve stenosis: Moreover, increased extracellular volume fraction, as visualized by late gadolinium enhancement (LGE), in combination with serum biomarkers such as transforming growth factor beta 1 (TGF-β1), is a potent marker of fibrosis in patients with AS and another strong predictor of an adverse outcome [31,32].